Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

DexCom Inc

DXCM
Current price
117.2 USD +0.83 USD (+0.71%)
Last closed 118.24 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 44 510 822 400 USD
Yield for 12 month +0.32 %
Week
Month
Year
DXCM
21.11.2021 - 28.11.2021

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121

Analytics

WallStreet Target Price

124.6 USD

P/E ratio

128.1538

Dividend Yield

0.41 %

Current Year

+2 909 800 000 USD

Last Year

+2 448 500 000 USD

Current Quarter

+975 000 000 USD

Last Quarter

+871 300 000 USD

Current Year

+1 883 100 000 USD

Last Year

+1 680 500 000 USD

Current Quarter

+623 300 000 USD

Last Quarter

+546 400 000 USD

Key Figures DXCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 659 600 000 USD
Operating Margin TTM 21.08 %
PE Ratio 128.1538
Return On Assets TTM 5.5 %
PEG Ratio 2.3891
Return On Equity TTM 18.42 %
Wall Street Target Price 124.6 USD
Revenue TTM 3 403 000 064 USD
Book Value 5.87 USD
Revenue Per Share TTM 8.8 USD
Dividend Share
Quarterly Revenue Growth YOY 26.7 %
Dividend Yield 0.41 %
Gross Profit TTM 1 883 100 000 USD
Earnings Share 0.91 USD
Diluted Eps TTM 0.91 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY 18.7 %
Profit Margin 11.08 %

Dividend Analytics DXCM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DXCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 0.41 %
Last Split Factor 4:1
Payout Ratio
Last Split Date 13.06.2022
Dividend Date

Stock Valuation DXCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 128.1538
Forward PE 68.0272
Enterprise Value Revenue 12.9267
Price Sales TTM 13.0799
Enterprise Value EBITDA 55.8738
Price Book MRQ 19.6264

Financials DXCM

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators DXCM

For 52 weeks

74.75 USD 139.55 USD
50 Day MA 93.62 USD
Shares Short Prior Month 21 061 456
200 Day MA 111.37 USD
Short Ratio 3.19
Shares Short 17 748 954
Short Percent 5.28 %